Management of Transfusion-Dependent Myelodysplastic Syndromes: Current and Emerging Strategies

By Elkabani Magda   List Alan F.  

American Journal of Cancer, Vol. 5, Iss. 2, 2006-01 ,pp. : 71-80

Adis International

Access to resources Recommend Favorite

Novel therapeutic strategies using hypomethylating agents in the treatment of myelodysplastic syndrome

By Ishikawa Takayuki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 10-15

Springer Publishing Company

Access to resources Recommend Favorite

Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes

By Xicoy Blanca   Jiménez María-José   García Olga   Bargay Joan   Martínez-Robles Violeta   Brunet Salut   Arilla María-Jesús   Pérez de Oteyza Jaime   Andreu Rafael   Casaño Francisco-Javier   Cervero Carlos-Javier   Bailén Alicia   Díez María   González Bernardo   Vicente Ana-Isabel   Pedro Carme   Bernal Teresa   Luño Elisa   Cedena María-Teresa   Palomera Luis   Simiele Adriana   Calvo José-Manuel   Marco Víctor   Gómez Eduardo   Gómez Marta   Gallardo David   Muñoz Juan   de Paz Raquel   Grau Javier   Ribera Josep-Maria   Benlloch Luis-Enrique   Sanz Guillermo  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1300-1303

Informa Healthcare

Access to resources Recommend Favorite

Myelofibrosis in primary myelodysplastic syndromes: Clinical and Biological Significance

By Marisavljević D.   Rolović Z.   Ćemerikić V.   Bošković D.   Ćolović M.  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 325-331

Humana Press, Inc

Access to resources Recommend Favorite

Hypocellular myelodysplastic syndromes: Clinical and biological significance

By Marisavljević Dragomir   Čemerikić Vesna   Rolović Zoran   Bošković Darinka   Čolović Milica  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 169-175

Humana Press, Inc

Access to resources Recommend Favorite